Can Guo Selected Research

Long Noncoding RNA

1/2022	Long non-coding RNAs are involved in alternative splicing and promote cancer progression.
1/2021	Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc.
1/2021	The long noncoding RNA AATBC promotes breast cancer migration and invasion by interacting with YBX1 and activating the YAP1/Hippo signaling pathway.
12/2020	Corrigendum to: Long non-coding RNA LOC284454 promotes migration and invasion of nasopharyngeal carcinoma via modulating the Rho/Rac signaling pathway.
9/2020	Upregulation of long non-coding RNA LOC284454 may serve as a new serum diagnostic biomarker for head and neck cancers.
1/2020	Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA.
1/2020	LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma.
1/2020	Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
4/2019	Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
1/2019	Long non-coding RNA LOC284454 promotes migration and invasion of nasopharyngeal carcinoma via modulating the Rho/Rac signaling pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Can Guo Research Topics

Disease

49	Neoplasms (Cancer) 11/2022 - 01/2016
15	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2016
14	Nasopharyngeal Carcinoma 11/2022 - 01/2018
7	Carcinogenesis 01/2022 - 01/2016
4	Epstein-Barr Virus Infections 01/2022 - 05/2006
3	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 09/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2020
2	Hypoxia (Hypoxemia) 09/2020 - 01/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2017 - 01/2017
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Disease Progression 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Liver Neoplasms (Liver Cancer) 04/2021
1	Graves Disease (Basedow Disease) 02/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2020
1	Stomach Neoplasms (Stomach Cancer) 12/2020
1	Multiple Myeloma 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 04/2019
1	Infections 01/2019
1	Herpesviridae Infections (Herpesvirus Infection) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2019

Drug/Important Bio-Agent (IBA)

18	Long Noncoding RNAIBA 01/2022 - 01/2016
14	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2006
12	Circular RNAIBA 11/2022 - 01/2018
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
8	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
5	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
5	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2016
4	Biological ProductsIBA 11/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 11/2022 - 12/2020
3	3' Untranslated Regions (3' UTR)IBA 01/2022 - 12/2020
2	Competitive Endogenous RNAIBA 01/2022 - 10/2018
2	Small Cytoplasmic RNAIBA 05/2021 - 03/2021
2	Antisense RNA (Anti-Sense RNA)IBA 01/2021 - 10/2018
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	RNA IIBA 04/2019 - 01/2019
2	Nucleic AcidsIBA 01/2019 - 02/2018
2	LipidsIBA 01/2019 - 02/2018
2	Glucose (Dextrose)FDA LinkGeneric 04/2018 - 01/2017
1	IonsIBA 06/2022
1	IronIBA 06/2022
1	Untranslated RNA (Noncoding RNA)IBA 06/2022
1	Hydroxyl RadicalIBA 06/2022
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2022
1	phosphatidylinositol 3-phosphateIBA 01/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	phosphatidylethanolamineIBA 01/2022
1	indacaterolIBA 01/2022
1	AMP-Activated Protein KinasesIBA 01/2022
1	TensinsIBA 01/2022
1	Beclin-1IBA 01/2022
1	Autophagy-Related Protein-1 HomologIBA 01/2022
1	RNA Splicing FactorsIBA 01/2022
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Circular DNAIBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Thyroglobulin FDA Link 01/2022
1	RNA Precursors (Precursor, mRNA)IBA 01/2022
1	6-methyladenineIBA 04/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2021
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	SolventsIBA 01/2021
1	ParaffinIBA 01/2021
1	Potassium Channels (Potassium Channel)IBA 01/2021
1	ezrinIBA 01/2021
1	Epstein-Barr virus MIRNBART12 microRNAIBA 12/2020
1	TubulinIBA 12/2020
1	CytokinesIBA 09/2020
1	Angiogenesis InhibitorsIBA 09/2020
1	GossypolIBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	matrigelIBA 04/2019
1	NexusIBA 04/2019
1	ProteomeIBA 01/2019
1	Thromboxane-A SynthaseIBA 01/2019
1	VaccinesIBA 01/2019

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2019
6	Immunotherapy 01/2022 - 11/2018
3	Precision Medicine 01/2021 - 07/2019
2	Drug Therapy (Chemotherapy) 10/2021 - 01/2021
1	Radiofrequency Ablation 04/2021
1	Operative Surgical Procedures 02/2021
1	Thyroidectomy 02/2021
1	Laser Therapy (Surgery, Laser) 01/2021